Triphosphate

Triphosphate

SCHEMBL1994740

O=P(O)(O)OP(=O)(O)OP(=O)(O)O.[KH].[NaH].[NaH]

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.60
BLM P54132 1/20 0.60
TDP1 Q9NUW8 1/20 0.60
BTN3A1 O00481 4/20 0.41
MVD P53602 3/20 0.35
CA4 P22748 1/20 0.32
FNTA P49354 2/20 0.31
FNTB P49356 1/20 0.31
PGGT1B P53609 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Triphosphate SCHEMBL17315008 1.00 FDPS (0.60) FDPSBLMTDP1BTN3A1MVD
Triphosphate SCHEMBL9502008 1.00 FDPS (0.60) FDPSBLMTDP1BTN3A1MVD
Triphosphate SCHEMBL29208984 1.00 FDPS (0.60) FDPSBLMTDP1BTN3A1MVD
Triphosphate SCHEMBL8063929 1.00 FDPS (0.60) FDPSBLMTDP1BTN3A1MVD
SCHEMBL3906359 0.97 FDPS (0.56) FDPSBLMTDP1BTN3A1MVD
SCHEMBL28089498 0.97 FDPS (0.56) FDPSBLMTDP1BTN3A1MVD
SCHEMBL10575750 0.97 FDPS (0.56) FDPSBLMTDP1BTN3A1MVD
Triphosphate SCHEMBL25284822 0.96 FDPS (0.64) FDPSBLMTDP1BTN3A1MVD
Triphosphate SCHEMBL5488462 0.96 FDPS (0.64) FDPSBLMTDP1BTN3A1MVD
Triphosphate SCHEMBL7510857 0.96 FDPS (0.64) FDPSBLMTDP1BTN3A1MVD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109613266-A It is a kind of detection glycosylated albumin and its concentration method, detection glycated amino acid oxidizing ferment -one amine oxidase and its concentration method 吉林大学 2019-04-12 CN disclosed
US-20130202713-A1 COATING OF PARTICLES COMPRISING A PHARMACEUTICALLY ACTIVE INGREDIENT WITH A CARBONATE SALT OR PHOSPHATE SALT LEK PHARMACEUTICALS D.D. (SI) 2013-08-08 US disclosed
US-20130115301-A1 COATING OF PARTICLES COMPRISING A PHARMACEUTICALLY ACTIVE INGREDIENT WITH A CARBONATE SALT OR PHOSPHATE SALT JAMNIK, Janko (SI) 2013-05-09 US disclosed
EP-2515884-A1 COATING OF PARTICLES COMPRISING A PHARMACEUTICALLY ACTIVE INGREDIENT WITH A CARBONATE SALT OR PHOSPHATE SALT LEK Pharmaceuticals d.d. (SI) 2012-10-31 EP disclosed
EP-2515885-A1 COATING OF PARTICLES COMPRISING A PHARMACEUTICALLY ACTIVE INGREDIENT WITH A CARBONATE SALT OR PHOSPHATE SALT LEK Pharmaceuticals d.d. (SI) 2012-10-31 EP disclosed
WO-2011076738-A1 COATING OF PARTICLES COMPRISING A PHARMACEUTICALLY ACTIVE INGREDIENT WITH A CARBONATE SALT OR PHOSPHATE SALT LEK PHARMACEUTICALS D.D. (SI) 2011-06-30 WO disclosed
WO-2011076743-A1 COATING OF PARTICLES COMPRISING A PHARMACEUTICALLY ACTIVE INGREDIENT WITH A CARBONATE SALT OR PHOSPHATE SALT LEK PHARMACEUTICALS D.D. (SI) 2011-06-30 WO disclosed
EP-2338480-A1 Coating of particles comprising a pharmaceutically active ingredient with a carbonate salt or phosphate salt LEK Pharmaceuticals d.d. (SI) 2011-06-29 EP disclosed